Table 1 Demographic and clinical characteristics in patients receiving tracheostomies
From: SARS-CoV-2 infection increases airway bleeding risk in patients after tracheostomies
Parameter | All (n = 44) | SARS-CoV-2 Positive (n = 29) | SARS-CoV-2 Negative (n = 15) | p Value |
|---|---|---|---|---|
Age, years (mean ± SD) | 63.1 ± 7.9 | 64.6 ± 8.2 | 60.4 ± 6.6 | 0.099 |
Male, n (%) | 40 (90.9) | 26 (89.7) | 14 (93.3) | 1.000 |
Temporary tracheostomy, n (%) | 33 (75.0) | 21 (72.4) | 12 (80.0) | - |
Permanent tracheostomy, n (%) | 11 (25.0) | 8 (27.6) | 3 (20.0) | - |
Airway bleeding, n (%) | 12 (27.3) | 11 (37.9) | 1 (6.7) | 0.035 |
Pneumonia, n (%) | 29 (65.9) | 22 (75.9) | 7 (46.7) | 0.053 |
Hypertension, n (%) | 10 (22.7) | 7 (24.1) | 3 (20.0) | 1.000 |
Diabetes, n (%) | 10 (22.7) | 8 (27.6) | 2 (13.3) | 0.452 |
Chronic kidney failure, n (%) | 3 (6.8) | 2 (6.9) | 1 (6.7) | 1.000 |
Malignancy, n (%) | 36 (81.8) | 23 (79.3) | 13 (86.7) | 0.695 |